CN113243531A - Medicated food for people with high uric acid content - Google Patents
Medicated food for people with high uric acid content Download PDFInfo
- Publication number
- CN113243531A CN113243531A CN202110611872.1A CN202110611872A CN113243531A CN 113243531 A CN113243531 A CN 113243531A CN 202110611872 A CN202110611872 A CN 202110611872A CN 113243531 A CN113243531 A CN 113243531A
- Authority
- CN
- China
- Prior art keywords
- parts
- uric acid
- people
- hyperuricemia
- chicory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title claims abstract description 45
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title claims abstract description 44
- 229940116269 uric acid Drugs 0.000 title claims abstract description 44
- 235000013305 food Nutrition 0.000 title description 5
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 15
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 15
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 15
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 15
- 229940026314 red yeast rice Drugs 0.000 claims abstract description 15
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 14
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 14
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 14
- 201000001431 Hyperuricemia Diseases 0.000 claims abstract description 14
- 241000234435 Lilium Species 0.000 claims abstract description 14
- 240000003915 Lophatherum gracile Species 0.000 claims abstract description 14
- 240000000249 Morus alba Species 0.000 claims abstract description 14
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 13
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 13
- 235000005911 diet Nutrition 0.000 claims abstract description 12
- 230000037213 diet Effects 0.000 claims abstract description 12
- 240000007087 Apium graveolens Species 0.000 claims abstract description 10
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims abstract description 10
- 235000010591 Appio Nutrition 0.000 claims abstract description 10
- 244000298479 Cichorium intybus Species 0.000 claims abstract 3
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 240000007171 Imperata cylindrica Species 0.000 claims abstract 3
- 239000001387 apium graveolens Substances 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 abstract description 12
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 208000002193 Pain Diseases 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 8
- 208000026435 phlegm Diseases 0.000 abstract description 8
- 208000004880 Polyuria Diseases 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 230000035619 diuresis Effects 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 3
- 206010030113 Oedema Diseases 0.000 abstract description 2
- 238000010306 acid treatment Methods 0.000 abstract 1
- 210000000941 bile Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 17
- 241000723343 Cichorium Species 0.000 description 11
- 241001092040 Crataegus Species 0.000 description 11
- 241001598107 Imperata Species 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 5
- 201000005569 Gout Diseases 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 235000001188 Peltandra virginica Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 206010067868 Skin mass Diseases 0.000 description 2
- 229940116731 Uricosuric agent Drugs 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003383 uricosuric agent Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 206010048302 Tubulointerstitial nephritis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 101710195583 Urinary protein 2 Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002529 benzbromarone Drugs 0.000 description 1
- WHQCHUCQKNIQEC-UHFFFAOYSA-N benzbromarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(Br)=C(O)C(Br)=C1 WHQCHUCQKNIQEC-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000850 chronic interstitial nephritis Toxicity 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960003081 probenecid Drugs 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
- 229960000894 sulindac Drugs 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A medicated diet for people with high uric acid content relates to the field of medicated diet, and solves the problems of several existing high uric acid treatment schemes. The invention comprises the following components in parts by weight: 1000-3000 parts of chicory, 1000-3000 parts of poria cocos, 1000-3000 parts of gardenia, 1000-3000 parts of lily, 1000-2000 parts of mulberry leaves, 1000-2000 parts of kudzu roots, 1000-3000 parts of lophatherum gracile, 1000-3000 parts of hawthorn, 1000-3000 parts of cogongrass rhizome, 1000-5000 parts of white gourds, 1000-3000 parts of red yeast rice, 1000-3000 parts of moringa leaves and 1000-3000 parts of celery seeds. The invention can regulate and nourish liver and kidney, clear heat and promote diuresis, clear liver and promote bile flow, promote qi circulation and remove blood stasis, dredge collaterals and relieve pain, eliminate phlegm, induce diuresis and reduce edema; controlling uric acid level, eliminating risk factors causing hyperuricemia, reducing uric acid synthesis and reducing incidence of hyperuricemia complications.
Description
Technical Field
The invention relates to a medicated diet, in particular to a medicated diet for people with high uric acid content.
Background
Hyperuricemia is the persistent abnormal increase of blood uric acid level caused by excessive uric acid production and/or reduced excretion in the body, and is the fourth highest in metabolic diseases in China at present. The clinical characteristics of hyperuricemia caused by increased synthesis or decreased excretion of uric acid are that hyperuricemia and urate crystallization, repeated acute arthritis caused by deposition, tophus deposition, tophaceous chronic arthritis, severe patients with joint deformity and dysfunction are caused, chronic interstitial nephritis and uric acid urinary calculus caused by kidney involvement are often caused, and the life quality of the patients is seriously influenced.
First, Chinese traditional treatment
High uric acid belongs to the categories of arthralgia, gout and the like in traditional Chinese medicine, and is mainly caused by congenital deficiency, dysfunction of spleen and kidney, improper diet (sexual overstrain and alcohol drinking to hurt the spleen), emotional internal injury, exogenous pathogenic factors and the like. Hyperuricemia is a syndrome of deficient origin with marked excess, and is marked by liver and kidney deficiency, spleen failure in transportation and transportation, and cold, damp and heat, turbid phlegm, blood stasis and obstruction of channels. Phlegm, dampness, stasis, heat, and weakness are risk factors for hyperuricemia.
The treatment of high uric acid is based on different clinical manifestations, or dispelling wind and eliminating dampness, or clearing heat and dispelling cold, or removing phlegm and removing blood stasis, or regulating and nourishing liver and kidney, dredging collaterals and relieving pain, and the treatment is carried out according to different syndromes.
1. Accumulation of damp-heat
The syndrome is characterized in that: the inflammation and pain of local joints, acute onset, and the symptoms of one or more joints are accompanied by fever, aversion to wind, thirst, irritability, headache, sweating, scanty and yellow urine, red tongue with yellow coating, yellow greasy coating, and wiry, smooth and rapid pulse.
Therapeutic method: clear heat and remove dampness, dredge collaterals and relieve pain.
2. Arthralgia due to wind-cold-dampness
The syndrome is characterized in that: a swollen and painful joint with difficulty in flexion and extension or subcutaneous nodules
A ganglion or a tophus. When wind pathogen prevails, the joints will wander and feel painful, or the joint will be averted to wind and generate heat; when the pathogenic cold prevails, the joint is severely cold and pain is localized; when the damp pathogen is excessive, the limbs and joints are heavy and painful, the pain is localized, and the skin is numb and numb. A thin, white or white and greasy coating on the tongue, and a wiry, tense or soft and slow pulse.
Therapeutic method: dispel wind and cold, remove dampness and dredge collaterals.
3. Phlegm-stasis obstructing the arthralgia
The syndrome is characterized in that: the arthralgia repeatedly attacks, and is not cured for a long time, light and heavy, or stabbing pain, immobility, arthrocele, even rigidity and deformity, difficult flexion and extension, subcutaneous nodules, or unchanged skin color, or purple dark skin color, or ulceration into fistulas, wiry or deep pulse, pale and fat or purple dark tongue, and thin and white or white and greasy tongue.
Therapeutic method: promoting blood circulation, removing blood stasis, eliminating phlegm and dredging collaterals.
4. Deficiency of liver and kidney
The syndrome is characterized in that: arthralgia and myalgia, swelling or stiffness and deformation, difficulty in flexion and extension, soreness and weakness of waist and knees, cold joints, aversion to cold, red tongue, white and thin coating and deep and weak pulse.
Therapeutic method: tonifying liver and kidney, eliminating arthralgia and dredging collaterals.
Other treatments
The Chinese patent medicine comprises: gout treating capsule, Simiao pill, cold-damp arthralgia treating granule, etc.
The traditional Chinese medicine has good curative effect on reducing blood uric acid in the intermittent and chronic gout attack periods, and has few toxic and side effects. However, some traditional Chinese medicine researches do not adopt a strict random control method, and can not strictly carry out the inclusion and the exclusion of cases and the evaluation of curative effect according to the recognized standard, so that the repeatability is poor, and the clinical significance is lacked.
Second and western medicine treatment
The Western medicine considers that the hyperuricemia is an important mark of gout, and the hyperuricemia can cause the increase of the blood uric acid concentration when the uric acid generation is increased or (and) the uric acid discharge is reduced.
Medical treatment
1. The common drugs for acute phase treatment are colchicine, non-steroidal anti-inflammatory drugs and glucocorticoid.
2. For intermittent and chronic treatments, the common uric acid lowering drugs are divided into two categories: one is a uricosuric agent and the other is an inhibitory uricogenic agent.
1) Uricosuric agents: probenecid, sulindac, benzbromarone, and the like;
2) uric acid production-inhibiting drugs: allopurines, and the like.
At present, the risk of kidney damage is increased by taking the medicine for a long time in western medicine treatment, and serious toxic and side effects are caused, so that the application of the western medicine is greatly limited.
Disclosure of Invention
In order to solve the problems of the traditional Chinese medicine and the western medicine in treating the hyperuricemia disease, the invention provides the medicated diet which is eaten by people with hyperuricemia.
The technical scheme adopted by the invention for solving the technical problem is as follows:
the invention relates to a medicated food for people with high uric acid content, which comprises the following components in parts by weight:
1000-3000 parts of chicory, 1000-3000 parts of poria cocos, 1000-3000 parts of gardenia, 1000-3000 parts of lily, 1000-2000 parts of mulberry leaves, 1000-2000 parts of kudzu roots, 1000-3000 parts of lophatherum gracile, 1000-3000 parts of hawthorn, 1000-3000 parts of cogongrass rhizome, 1000-5000 parts of white gourds, 1000-3000 parts of red yeast rice, 1000-3000 parts of moringa leaves and 1000-3000 parts of celery seeds.
As a preferred embodiment, the medicinal diet for people with high uric acid comprises the following components in parts by weight:
1500 parts of chicory, 1500 parts of poria cocos, 1500 parts of gardenia, 1500 parts of lily, 1000 parts of mulberry leaf, 1000 parts of kudzuvine root, 1500 parts of lophatherum gracile, 1500 parts of hawthorn, 1500 parts of cogongrass rhizome, 3000 parts of white gourd, 1500 parts of red yeast rice, 1500 parts of moringa oleifera leaf and 1500 parts of celery seed.
The invention has the beneficial effects that: the invention is composed of chicory, tuckahoe, gardenia, lily, mulberry leaf, kudzu root, lophatherum gracile, hawthorn, lalang grass rhizome and other edible and medicinal substances, and the combination of the products has the functions of regulating and nourishing liver and kidney, clearing heat and promoting diuresis, clearing liver and benefiting gallbladder, promoting qi circulation and removing blood stasis, and dredging collaterals and relieving pain; the white gourd, the red yeast rice, the moringa oleifera leaves, the celery seeds and the like form an accurate nutrition strengthening part, and the white gourd, the red yeast rice, the moringa oleifera leaves, the celery seeds and the like can eliminate phlegm, promote urination, reduce swelling, reduce the synthesis of uric acid, control the uric acid level, improve the inflammatory cytokine level in peripheral tissues and relieve the structural damage of the liver and the oxidative stress.
Clinical verification for over ten years proves that the medicinal diet for people with high uric acid can eliminate the risk factors causing hyperuricemia, reduce the synthesis of uric acid and reduce the incidence of hyperuricemia complications.
In addition, the edible and medicinal substances and the nutrition-enriched substances used in the invention are safe and have no toxic or side effect.
Detailed Description
The invention relates to a medicated food for people with high uric acid content, which comprises the following components in parts by weight:
1000-3000 parts of chicory, 1000-3000 parts of poria cocos, 1000-3000 parts of gardenia, 1000-3000 parts of lily, 1000-2000 parts of mulberry leaves, 1000-2000 parts of kudzu roots, 1000-3000 parts of lophatherum gracile, 1000-3000 parts of hawthorn, 1000-3000 parts of cogongrass rhizome, 1000-5000 parts of white gourds, 1000-3000 parts of red yeast rice, 1000-3000 parts of moringa leaves and 1000-3000 parts of celery seeds.
The functions and effects of the components of the invention are as follows:
the invention consists of chicory, tuckahoe, gardenia, lily, mulberry leaf, kudzu root, lophatherum gracile, hawthorn, lalang grass rhizome and other edible and medicinal substances, and the combination of the products has the functions of regulating and nourishing liver and kidney, clearing heat and promoting diuresis, clearing liver and benefiting gallbladder, promoting qi circulation and removing blood stasis, and dredging collaterals and relieving pain.
The invention uses white gourd, red yeast rice, moringa leaves, celery seeds and the like to form an accurate nutrition strengthening part, and can eliminate phlegm, induce diuresis to reduce edema, reduce the synthesis of uric acid, control the uric acid level, improve the inflammatory cytokine level in peripheral tissues and relieve the structural damage of the liver and oxidative stress.
The preparation method of the medicated food for people with high uric acid specifically comprises the following steps:
firstly, weighing raw materials according to the components and the using amount of the invention for later use;
secondly, all the raw materials are sequentially put into a mixer to be uniformly mixed, and the mixture is sealed for later use on the premise of no caking and solidification;
thirdly, putting the uniformly mixed composite powder into a vacuum drier for drying;
sampling to detect heavy metal and microbe;
detecting unqualified mixed materials, retreating according to reasons, and subpackaging qualified mixed materials;
sixthly, the subpackaged product enters an outer packing chamber for outer packing;
and seventhly, carrying out quality inspection on site, and warehousing after the quality inspection is qualified.
The invention relates to an edible method of a medicated diet for people with high uric acid, which comprises the following steps:
soaking the product in warm water for 1 bag, stirring, and taking after appropriate temperature. 1 bag each time, 2 times daily.
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The specific components and amounts of this example are as follows:
1500 parts of chicory, 1500 parts of poria cocos, 1500 parts of gardenia, 1500 parts of lily, 1000 parts of mulberry leaf, 1000 parts of kudzuvine root, 1500 parts of lophatherum gracile, 1500 parts of hawthorn, 1500 parts of cogongrass rhizome, 3000 parts of white gourd, 1500 parts of red yeast rice, 1500 parts of moringa oleifera leaf and 1500 parts of celery seed.
The preparation process of this example is as follows:
firstly, weighing raw materials according to the components and the using amount of the invention for later use;
secondly, all the raw materials are sequentially put into a mixer to be uniformly mixed, and the mixture is sealed for later use on the premise of no caking and solidification;
thirdly, putting the uniformly mixed composite powder into a vacuum drier for drying;
sampling to detect heavy metal and microbe;
detecting unqualified mixed materials, retreating according to reasons, and subpackaging qualified mixed materials;
sixthly, the subpackaged product enters an outer packing chamber for outer packing;
and seventhly, carrying out quality inspection on site, and warehousing after the quality inspection is qualified.
Example 2
The specific components and amounts of this example are as follows:
1600 parts of chicory, 1500 parts of poria cocos, 1400 parts of cape jasmine, 1200 parts of lily, 1100 parts of mulberry leaf, 1000 parts of radix puerariae, 1600 parts of lophatherum gracile, 1500 parts of hawthorn, 1500 parts of cogongrass rhizome, 3100 parts of wax gourd, 1500 parts of red yeast rice, 1500 parts of moringa oleifera leaf and 1500 parts of celery seed.
The procedure of this example was the same as in example 1.
Example 3
The specific components and amounts of this example are as follows:
1400 parts of chicory, 1600 parts of tuckahoe, 1400 parts of gardenia, 1600 parts of lily, 1000 parts of mulberry leaf, 1000 parts of kudzuvine root, 1400 parts of lophatherum gracile, 1600 parts of hawthorn, 1400 parts of cogongrass rhizome, 3000 parts of white gourd, 1400 parts of red yeast rice, 1600 parts of moringa oleifera leaf and 1600 parts of celery seed.
The procedure of this example was the same as in example 1.
Example 4
The specific components and amounts of this example are as follows:
1450 parts of chicory, 1500 parts of poria cocos, 1550 parts of gardenia, 1500 parts of lily, 1050 parts of mulberry leaves, 1050 parts of kudzuvine roots, 1500 parts of lophatherum gracile, 1500 parts of hawthorn, 1400 parts of cogongrass rhizome, 3000 parts of white gourd, 1450 parts of red yeast rice, 1550 parts of moringa oleifera leaves and 1500 parts of celery seeds.
The procedure of this example was the same as in example 1.
Example 5
The specific components and amounts of this example are as follows:
1500 parts of chicory, 1550 parts of poria cocos, 1500 parts of gardenia, 1450 parts of lily, 1200 parts of mulberry leaves, 1100 parts of kudzu roots, 1500 parts of lophatherum gracile, 1400 parts of hawthorn, 1500 parts of cogongrass rhizome, 2800 parts of white gourd, 1400 parts of red yeast rice, 1600 parts of moringa oleifera leaves and 1500 parts of celery seeds.
The procedure of this example was the same as in example 1.
Example 6
The specific components and amounts of this example are as follows:
1550 parts of chicory, 1500 parts of poria cocos, 1550 parts of gardenia, 1600 parts of lily, 1050 parts of mulberry leaves, 1100 parts of kudzuvine roots, 1500 parts of lophatherum gracile, 1400 parts of hawthorn, 1500 parts of cogongrass rhizome, 3000 parts of white gourd, 1500 parts of red yeast rice, 1500 parts of moringa leaves and 1250 parts of celery seeds.
The procedure of this example was the same as in example 1.
Clinical trial
Case 1: high uric acid
Patient name: certain Liu (a certain herb)
Age: age 52 years old
Sex: woman
Occupation: staff member
Hospital diagnosis: high uric acid
Before the traditional Chinese medicine preparation is taken, uric acid 629 ≠ which is caused by physical examination and is often hypodynamia and aching in the whole body. After the medicine is taken for 30 days, the physical examination result of uric acid 492 ↓, physical strength is strong, and the ache condition is relieved.
Case 2: high uric acid
Patient name: something in plum
Age: age 56
Sex: for male
Occupation: peasants
Hospital diagnosis: high uric acid
Before the traditional Chinese medicine is taken, uric acid 576 ≠ as a result of physical examination, and other obvious symptoms are not seen yet. After taking the present invention for 50 days, the result of physical examination is that uric acid 432 (normal).
Case 3: high uric acid
Patient name: something in plum
Age: age 62 years old
Sex: for male
Occupation: retire
Hospital diagnosis: high uric acid and nephritis
Before the invention is taken, the physical examination results comprise uric acid 549 ≠ 150 ℃,. uromicroalbumin 150 ℃,. urobumin 3 +. After taking the invention for 50 days, the physical examination results comprise uric acid 364 (normal), urinary microalbumin 140 ≠ and urinary protein 2 +.
The invention discloses a medicated diet for people with high uric acid content, and the method can be realized by appropriately improving process parameters by taking the contents as reference by the technical personnel in the field. It is expressly intended that all such similar substitutes and modifications which would be obvious to one skilled in the art are deemed to be included in the invention. While the invention has been described in terms of preferred embodiments, it will be apparent to those skilled in the art that the technology can be practiced and applied by modifying or appropriately combining the products described herein without departing from the spirit and scope of the invention.
Claims (2)
1. The medicated diet for people with high uric acid content is characterized by comprising the following components in parts by weight:
1000-3000 parts of chicory, 1000-3000 parts of poria cocos, 1000-3000 parts of gardenia, 1000-3000 parts of lily, 1000-2000 parts of mulberry leaves, 1000-2000 parts of kudzu roots, 1000-3000 parts of lophatherum gracile, 1000-3000 parts of hawthorn, 1000-3000 parts of cogongrass rhizome, 1000-5000 parts of white gourds, 1000-3000 parts of red yeast rice, 1000-3000 parts of moringa leaves and 1000-3000 parts of celery seeds.
2. The medicated diet for people with hyperuricemia according to claim 1, which is characterized by comprising the following components in parts by weight:
1500 parts of chicory, 1500 parts of poria cocos, 1500 parts of gardenia, 1500 parts of lily, 1000 parts of mulberry leaf, 1000 parts of kudzuvine root, 1500 parts of lophatherum gracile, 1500 parts of hawthorn, 1500 parts of cogongrass rhizome, 3000 parts of white gourd, 1500 parts of red yeast rice, 1500 parts of moringa oleifera leaf and 1500 parts of celery seed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110611872.1A CN113243531A (en) | 2021-06-02 | 2021-06-02 | Medicated food for people with high uric acid content |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110611872.1A CN113243531A (en) | 2021-06-02 | 2021-06-02 | Medicated food for people with high uric acid content |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113243531A true CN113243531A (en) | 2021-08-13 |
Family
ID=77185934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110611872.1A Pending CN113243531A (en) | 2021-06-02 | 2021-06-02 | Medicated food for people with high uric acid content |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113243531A (en) |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824232A (en) * | 2005-12-29 | 2006-08-30 | 颜怀伟 | Medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating alcoholism and its manufacturing method |
CN101732601A (en) * | 2009-12-25 | 2010-06-16 | 王斐芬 | Chinese medicament for treating influenza |
CN103053953A (en) * | 2013-01-31 | 2013-04-24 | 河南大学 | Functional bean sprouts prepared from Chinese herbal medicines used as both food and medicine and method for preparing functional bean sprouts |
CN103285288A (en) * | 2013-06-26 | 2013-09-11 | 蒋梅 | Medicament for treating chronic cardiac insufficiency |
WO2014005224A1 (en) * | 2012-07-03 | 2014-01-09 | Majambu Mbikay | Quercetin-3-glucoside and uses thereof |
CN103734737A (en) * | 2013-12-06 | 2014-04-23 | 颍上县天好食品有限公司 | Five-cereal health powder and preparation method thereof |
CN104872639A (en) * | 2015-04-22 | 2015-09-02 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food suitable for patients with lung cancer |
CN107136377A (en) * | 2017-06-21 | 2017-09-08 | 武汉万松堂健康产业有限公司 | A kind of compound solid beverage for being directed to gout and people with high uric acid and preparation method thereof |
CN108403987A (en) * | 2018-05-11 | 2018-08-17 | 刘松松 | One kind preventing antipodagric witloof jasmine tea |
CN110960638A (en) * | 2019-12-30 | 2020-04-07 | 李刚 | Composition for reducing uric acid and preparation method thereof |
CN112438397A (en) * | 2020-12-11 | 2021-03-05 | 安徽国膳生物科技有限公司 | Medicated diet for people with hyperglycemia |
CN112439030A (en) * | 2019-09-04 | 2021-03-05 | 王忠民 | Medicine for quickly reducing uric acid |
CN113331415A (en) * | 2021-06-02 | 2021-09-03 | 膳行天下(吉林)科技发展有限公司 | Medicated diet for people with sleep disorder |
-
2021
- 2021-06-02 CN CN202110611872.1A patent/CN113243531A/en active Pending
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824232A (en) * | 2005-12-29 | 2006-08-30 | 颜怀伟 | Medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating alcoholism and its manufacturing method |
CN101732601A (en) * | 2009-12-25 | 2010-06-16 | 王斐芬 | Chinese medicament for treating influenza |
WO2014005224A1 (en) * | 2012-07-03 | 2014-01-09 | Majambu Mbikay | Quercetin-3-glucoside and uses thereof |
CN103053953A (en) * | 2013-01-31 | 2013-04-24 | 河南大学 | Functional bean sprouts prepared from Chinese herbal medicines used as both food and medicine and method for preparing functional bean sprouts |
CN103285288A (en) * | 2013-06-26 | 2013-09-11 | 蒋梅 | Medicament for treating chronic cardiac insufficiency |
CN103734737A (en) * | 2013-12-06 | 2014-04-23 | 颍上县天好食品有限公司 | Five-cereal health powder and preparation method thereof |
CN104872639A (en) * | 2015-04-22 | 2015-09-02 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food suitable for patients with lung cancer |
CN107136377A (en) * | 2017-06-21 | 2017-09-08 | 武汉万松堂健康产业有限公司 | A kind of compound solid beverage for being directed to gout and people with high uric acid and preparation method thereof |
CN108403987A (en) * | 2018-05-11 | 2018-08-17 | 刘松松 | One kind preventing antipodagric witloof jasmine tea |
CN112439030A (en) * | 2019-09-04 | 2021-03-05 | 王忠民 | Medicine for quickly reducing uric acid |
CN110960638A (en) * | 2019-12-30 | 2020-04-07 | 李刚 | Composition for reducing uric acid and preparation method thereof |
CN112438397A (en) * | 2020-12-11 | 2021-03-05 | 安徽国膳生物科技有限公司 | Medicated diet for people with hyperglycemia |
CN113331415A (en) * | 2021-06-02 | 2021-09-03 | 膳行天下(吉林)科技发展有限公司 | Medicated diet for people with sleep disorder |
Non-Patent Citations (2)
Title |
---|
吴美音等: "菊苣、葛根、桑叶配方对高尿酸合并关节炎小鼠的降尿酸和痛风性关节炎的干预效果", 《食品工业科技》 * |
王凤山等: "长期低热从湿热论治", 《实用中医内科杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108310320A (en) | A kind of externally applied drug and preparation method thereof for treating gout | |
CN102225102B (en) | Medicinal liquor for treating rheumatoid arthritis | |
CN104815318A (en) | Traditional Chinese medicine preparation for treating gout | |
CN111097029A (en) | Health care product for assisting gout and preparation method thereof | |
CN104984148B (en) | A kind of clinical Chinese medicine wound care compositions | |
CN103405653B (en) | External preparation for treating gouty arthritis | |
CN113243531A (en) | Medicated food for people with high uric acid content | |
CN108686079A (en) | A kind of Chinese medicine composition for treating wound, diabetes and exanthemv | |
CN104721445A (en) | Traditional Chinese medicine ointment for treating bedsores and preparation method thereof | |
CN104288255A (en) | Traditional Chinese medicine preparation for treating severe acute pancreatitis | |
CN113018399A (en) | Chinese herbal medicine product for treating calendar-joint wind, gout and condyle pain | |
CN110876796A (en) | Traditional Chinese medicine composition for treating acute gout attack and preparation method and application thereof | |
CN103520492B (en) | A kind of liniment of prevention and therapy gout and preparation method | |
CN111214638A (en) | Traditional Chinese medicine liniment for treating gout and preparation method thereof | |
CN110478416A (en) | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis | |
CN104857089B (en) | A kind of decoction for treating rheumatism and rheumatoid arthritis and preparation method thereof | |
CN104352737A (en) | Traditional Chinese medicinal preparation for treating rheumatic low back and leg pain | |
CN111035708A (en) | Olive oil aloe burn cream | |
CN110403995B (en) | Traditional Chinese medicine composition for treating superficial phlebitis and preparation, use methods and application thereof | |
CN102258589B (en) | Deer blood medicinal wine for treating rheumatoid arthritis | |
CN107019788A (en) | It is a kind of to treat Chinese medicine composition of tinea pedis and preparation method thereof | |
CN113318157A (en) | Externally-applied detumescence traditional Chinese medicine composition for treating acute gout and preparation method thereof | |
CN105616947A (en) | Heat and dampness removing traditional Chinese medicine for treating acute gouty arthritis | |
CN105232799A (en) | Bathing liquid for treating acute gout | |
CN104971210A (en) | External lotion for treating tinea pedis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220727 Address after: 130000 group 7, Da Shi Jia Wo Bao Tun, Chengguang village, Changde street, Kuancheng District, Changchun City, Jilin Province Applicant after: Zhao Tian Address before: 130000 room 1001, building 23, Zone G, phase II, blue harbor, No. 759, Huigong Road, Erdao District, Changchun City, Jilin Province Applicant before: Shanxingtianxia (Jilin) Technology Development Co.,Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210813 |